Catawba Capital Management’s Amgen AMGN Stock Holding History

Catawba Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.09M	Buy	5,882 +1,070	+22%	+$189K	0.26%	88
2018 Q1	$820K	Buy	4,812 +165	+4%	+$30.3K	0.2%	98
2017 Q4	$808K	Buy	4,647 +205	+5%	+$36.3K	0.18%	110
2017 Q3	$828K	Buy	4,442 +130	+3%	+$23K	0.19%	104
2017 Q2	$743K	Sell	4,312 -222	-5%	-$36.1K	0.17%	119
2017 Q1	$744K	Buy	4,534 +1,464	+48%	+$243K	0.16%	129
2016 Q4	$449K	Sell	3,070 -2,250	-42%	-$339K	0.1%	163
2016 Q3	$887K	Buy	5,320 +1,285	+32%	+$217K	0.21%	108
2016 Q2	$614K	Buy	4,035 +775	+24%	+$120K	0.15%	131
2016 Q1	$489K	Hold	3,260	–	–	0.12%	143
2015 Q4	$529K	Sell	3,260 -220	-6%	-$34.6K	0.14%	128
2015 Q3	$481K	Sell	3,480 -2,925	-46%	-$461K	0.13%	136
2015 Q2	$983K	Sell	6,405 -526	-8%	-$84.3K	0.23%	98
2015 Q1	$1.11M	Sell	6,931 -765	-10%	-$120K	0.25%	90
2014 Q4	$1.23M	Sell	7,696 -505	-6%	-$78.7K	0.28%	89
2014 Q3	$1.15M	Sell	8,201 -680	-8%	-$88.8K	0.27%	91
2014 Q2	$1.05M	Sell	8,881 -220	-2%	-$25.5K	0.24%	99
2014 Q1	$1.12M	Sell	9,101 -100	-1%	-$12.1K	0.27%	92
2013 Q4	$1.05M	Buy	9,201 +160	+2%	+$18.2K	0.25%	94
2013 Q3	$1.01M	Buy	9,041 +360	+4%	+$39K	0.27%	89
2013 Q2	$856K	Buy	+8,681	New	+$901K	0.24%	97

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Catawba Capital Management's AMGN Position: Q2 2018 in Review

Catawba Capital Management increased its Amgen (AMGN) stake by 22% in Q2 2018, buying an estimated $189K and bringing the position to 5,882 shares worth $1.09M. The position accounts for 0.26% of the portfolio, ranked #88.

Catawba Capital Management first reported a position in AMGN in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.23M in Q4 2014. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

Catawba Capital Management held 5,882 shares of Amgen worth $1.09M as of Q2 2018.
Catawba Capital Management bought 1,070 Amgen shares in Q2 2018, an estimated $189K.
Amgen made up 0.26% of Catawba Capital Management's portfolio in Q2 2018, its #88 holding.
Catawba Capital Management first reported a position in Amgen in Q2 2013 and has held it in 21 quarters since.
Catawba Capital Management's Amgen position peaked at $1.23M in Q4 2014.
1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.